In the States
REPORT: Pharmaceutical bills & laws in the states in 2008 More
NEW HAMPSHIRE: Federal Appeals Court Backs Limit on Pharmaceutical Marketing More
MASSACHUSETTS: New rules for Pharmaceutical and Device Marketing Law Delayed More
OHIO: Cleveland Clinic Begins Public Disclosure of Physician-Industry Relationships More
MARYLAND: Hearing on Legislation Regulating Sale, Use of Prescription Data More
|
Outrages of the Week
Doctors Claim Glaxo Dismissed Worries on Avandia More
Popular Radio Host Has Drug Company Ties More
|
Prices and Access to Healthcare
More Than Half of Chronically Ill U.S. Adults Skip Care Due to Costs More
Miracle Drugs Becoming a Significant Expense for Employers More
Drugmakers' Moves to Block Generics May Have Cost Europeans Billions More
Downturn Forcing Choice Between Medical, Home Payments More
|
Fraud and Abuse
Wisconsin False Claims Act Qualifies Under the Deficit Reduction Act More
AARP Hires Outside Investigation of its Own Marketing More
|
Advertising and Marketing
NH Data-Mining Ban Upheld More
Court Upholds NH Law Prohibiting Sales of Physicians' Prescribing Histories More
FTC Proposes Updates to Endorsement Guidelines More
Roche Exec: DTC Ads Hurt Big Pharma More
J&J Yanks Mom-Offending Motrin Ad More
Device Makers Illegally Advertise On YouTube? More
Will A Big Pharma Pusher Come To The Big Screen? More
Consumer Advertising Spend Drops as New Drugs Dwindle More
|
Conflicts of Interest
Harvard Students Demand Pharma Disclosures More
Pharma And Its Influence On The Media More
|
Pharma Watch
Abbott to Pay $184 Million In Tricor Suits More
Novartis Says Research Shift Has Bolstered Drug Pipeline More
Genentech Carries On, as Roche Deal Simmers on Back Burner More
Merck Seeks to Regain Industry Leadership as Shares Languish More
|
PBM Watch
McKesson Paying $350 Million to Settle Drug-Price Litigation More
UMass Med Spin Off Shakes Up Pharmacy Biz More
Challenges Facing Independent Pharmacies More |
Medicare
Groups Criticize Part D Charges, Lack of Website Transparency More
A Shot in the Arm for Part D: Boosting Customer Communications More
When Is the Lowest Cost Prescription Drug Plan ... Not? More
Medicare Advantage: Ripping Off Medicare More
Insurers' Medicare Plans Raise Costs, Not Quality More
Medicare Advantage Payments May be Reined In More
|
Medicaid
States Ask Feds for Funds for SCHIP, Medicaid More
Series Examines Medicaid Income Eligibility Limits More
Updated Primers On Medicaid and Medicare Programs More
Medicaid Paid Nearly $198M for More Than 100 Unapproved Drugs More
New Rules Allow States to Set Premiums and Higher Co-Pays More
|
Patents and Generics
AstraZeneca Wins Legal Halt Of Rival Drug More
Sanofi Settles Suits With Rivals On U.S. Sales of Generic Allegra More
Latest EU Raids Prod Drug Firms Over Conduct More
Insurers' Drug-Switching Push Prompts Warning More
Drugmaker Tries to Outwit Generics More
Generics Industry Statement on FTC Biogenetics Roundtable More
FTC Holds Roundtable On Follow-On Biologics More
JAMA Study Confirms Generics Are As Good Brand-Name Meds More
|
Safety and Clinical Trials
Antidepressants Prescribed to Children, Babies More
Experts Warn FDA of Frequent Use of Antipsychotics in Children More
Study Questions Safety, Efficacy for Off-Label Uses More
Western Pharmaceutical Companies Facie Scrutiny Over Clinical Trials in Developing Countries More
ALLHAT Drug Trial Revisited More
Researchers Increasingly Conduct 'Real World' Clinical Trials More
Medtronic Hit With Patient Lawsuit Over Bone-Stimulator Infuse More
|
Electronic Records
Efforts To Encourage Physicians To Adopt E-Prescribing Technology More
UnitedHealth Takes On Microsoft, Google With Online Health Venture More
|
Importation
EU Executive Under Pressure to Change Drugs Reforms More
Minimizing Risks of Crossing Borders for Prescriptions More
|
Editorials and Opinions
Obama Presidency Could Bring Cheaper Medicines, Universal Coverage More
Less-Padded Prescriptions: A Unique Opportunity to Lower Drug Prices More
|
